Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 5-6, 2007, Pages 301-308

  Plourde, Mélanie ^a,b   Fortier, Mélanie ^a   Vandal, Milène ^a,b   Tremblay Mercier, Jennifer ^a,b   Freemantle, Erika ^a,b   Bégin, Michel ^a   Pifferi, Fabien ^a   Cunnane, Stephen C ^a,b  

^a Research Centre on Aging   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; PHOSPHOLIPID; PLACEBO;

AGING; ALZHEIMER DISEASE; ARTICLE; BIOLOGY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITIVE DEFECT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ELDERLY CARE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; LITERATURE; MENTAL DETERIORATION; METHODOLOGY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN METABOLISM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CHOLESTEROL ESTERS; COGNITION; DOCOSAHEXAENOIC ACIDS; HUMANS; PHOSPHOLIPIDS;

EID: 36649014315     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.10.024     Document Type: Article

References (45)

1. Gillette Guyonnet S., Abellan Van Kan G., Andrieu S., et al. IANA task force on nutrition and cognitive decline with aging. J. Nutr. Health Aging 11 (2007) 132-152
2. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., and Wilson R.S. Fish consumption and cognitive decline with age in a large community study. Arch. Neurol. 62 (2005) 1849-1853
3. van Gelder B.M., Tijhuis M., Kalmijn S., and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 85 (2007) 1142-1147
4. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., and Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 (2000) 1305-1312
5. Corrigan F.M., Van Rhijn A.G., Ijomah G., et al. Tin and fatty acids in dementia. Prostaglandins Leukot. Essent. Fatty Acids 43 (1991) 229-238
6. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
7. Cunnane S.C., Plourde M., Vandal M., Freemantle E., Tremblay-Mercier J., and Bégin M. Linking low docosahexaenoic acid intake to Alzheimer' disease: caution recommended. Oléagineux Corps gras et Lipides 14 (2007) 177-181
8. Maclean C.H., Issa A.M., Newberry S.J., et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evid. Rep. Technol. Assess. (Summ.) (2005) 1-3
9. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., and Folsom A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 85 (2007) 1103-1111
10. Schaefer E.J., Bongard V., Beiser A.S., et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol. 63 (2006) 1545-1550
11. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63 (2006) 1402-1408
12. Kotani S., Sakaguchi E., Warashina S., et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 56 (2006) 159-164
13. Suzuki H., Morikawa Y., and Takahashi H. Effect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Rev. Nutr. Diet 88 (2001) 68-71
14. Terano T., Fujishiro S., Ban T., et al. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 34 Suppl. (1999) S345-S346
15. Laurin D., Verreault R., Lindsay J., Dewailly E., and Holub B.J. Omega-3 fatty acids and risk of cognitive impairment and dementia. J. Alzheimers Dis. 5 (2003) 315-322
16. Benton A.L., Eslinger P.J., and Damasio A.R. Normative observations on neuropsychological test performances in old age. J. Clin. Neuropsychol. 3 (1981) 33-42
17. Tully A.M., Roche H.M., Doyle R., et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br. J. Nutr. 89 (2003) 483-489
18. Nikkari T., Luukkainen P., Pietinen P., and Puska P. Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat. Ann. Med. 27 (1995) 491-498
19. Arterburn L.M., Hall E.B., and Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83 (2006) 1467S-1476S
20. Rees D., Miles E.A., Banerjee T., et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am. J. Clin. Nutr. 83 (2006) 331-342
21. Rodriguez-Palmero M., Lopez-Sabater M.C., Castellote-Bargallo A.I., de la Torre-Boronat M.C., and Rivero-Urgell M. Administration of low doses of fish oil derived N-3 fatty acids to elderly subjects. Eur. J. Clin. Nutr. 51 (1997) 554-560
22. Crawford M.A., Costeloe K., Ghebremeskel K., Phylactos A., Skirvin L., and Stacey F. Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies?. Am. J. Clin. Nutr. 66 4 Suppl. (1997)
23. Cunnane S.C., Francescutti V., Brenna J.T., and Crawford M.A. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 35 (2000) 105-111
24. Svennerholm L., Bostrom K., and Jungbjer B. Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol. (Berlin) 94 (1997) 345-352
25. Kalpouzos G., Chetelat G., Baron J.C., et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol. Aging (2007)
26. Matsuda H., Kitayama N., Ohnishi T., et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nucl. Med. 43 (2002) 304-311
27. Guan Z., Wang Y., Cairns N.J., Lantos P.L., Dallner G., and Sindelar P.J. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J. Neuropathol. Exp. Neurol. 58 (1999) 740-747
28. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., and Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23 (1998) 81-88
29. Corrigan F.M., Horrobin D.F., Skinner E.R., Besson J.A., and Cooper M.B. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int. J. Biochem. Cell Biol. 30 (1998) 197-207
30. Kitajka K., Sinclair A.J., Weisinger R.S., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc. Natl. Acad. Sci. USA 101 (2004) 10931-10936
31. Florent-Bechard S., Malaplate-Armand C., Koziel V., et al. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. J. Neurol. Sci. (2007)
32. Bazan N.G. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15 (2005) 159-166
33. Lim G.P., Calon F., Morihara T., et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25 (2005) 3032-3040
34. Calon F., Lim G.P., Yang F., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
35. Lukiw W.J., Cui J.G., Marcheselli V.L., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115 (2005) 2774-2783
36. Ximenes da Silva A., Lavialle F., Gendrot G., Guesnet P., Alessandri J.M., and Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J. Neurochem. 81 (2002) 1328-1337
37. Pifferi F., Roux F., Langelier B., et al. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J. Nutr. 135 (2005) 2241-2246
38. Gale C.R., Walton S., and Martyn C.N. Foetal and postnatal head growth and risk of cognitive decline in old age. Brain 126 (2003) 2273-2278
39. S.I. Rapoport, in: ISSFAL (conference abstract), Cairns, Australia, 2006.
40. Mattson M.P., Pedersen W.A., Duan W., Culmsee C., and Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann. NY Acad. Sci. 893 (1999) 154-175
41. Freemantle E., Vandal M., Tremblay-Mercier J., et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 213-220
42. Dewailly E., Blanchet C., Gingras S., Lemieux S., and Holub B.J. Fish consumption and blood lipids in three ethnic groups of Quebec (Canada). Lipids 38 (2003) 359-365
43. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., et al. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71 (2000) 179S-188S
44. Plourde M., and Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 32 (2007) 619-634
45. Bakewell L., Burdge G.C., and Calder P.C. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br. J. Nutr. 96 (2006) 93-99